Democratic Sens. Elizabeth Warren (Mass.) and Tina Smith (Minn.) are reintroducing legislation aimed at strengthening U.S. pharmaceutical supply chains, warning the U.S. is overly relying on other countries for medications.
The Pharmaceutical Supply Chain Defense and Enhancement Act was first introduced in 2020, not long after the start of the COVID-19 pandemic. The bill was spurred by concerns over the U.S.'s pharmaceutical supply chain resilience.
The provisions of the bill...